Literature DB >> 10871206

Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats.

T Evans1, D X Deng, S Chen, S Chakrabarti.   

Abstract

Endothelins (ETs) are a family of vasoactive peptides that have mitogenic properties and have also been associated with altered long-term nuclear signaling. We have previously shown that mRNA levels for ET-1, ET-3, and their receptors are upregulated under hyperhexosemic conditions. In this study, an endothelin antagonist was used to assess the effects of endothelin blockage on the production of two basement membrane transcripts, fibronectin and collagen alpha1 (IV). The microvascular basement membranes were analyzed using ultrastructural morphometry. Streptozotocin-induced diabetic rats, galactose-fed rats (30% galactose in diet), and nondiabetic, non-galactose-fed control rats were studied after 1-month and 6-month follow-up. Simultaneously, similar animal groups were treated with a general ET receptor blocker (bosentan, 100 mg x kg(-1) x day(-1)) and investigated. Semiquantitative reverse transcription-polymerase chain reaction for fibronectin and collagen alpha1 (IV) was conducted after 1 month of follow-up with comparison to beta-actin housekeeping gene using slot blot hybridization and densitometry. Basement membrane thickness was assessed after 6 months of follow-up in diabetic rats, using the orthogonal intercept method. After 1 month of follow-up, increased fibronectin and collagen alpha1 (IV) mRNA were present in the retina of diabetic and galactosemic animals, and the bosentan-treated groups exhibited mRNA levels similar to the control animals. After 6 months of follow-up, diabetes and galactose feeding induced basement membrane thickening, which was partially prevented by bosentan treatment. The above findings indicate that increased production of extracellular matrix proteins leading to thickening of microvascular basement membrane, secondary to hyperhexosemia, may be mediated via augmented ET production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871206     DOI: 10.2337/diabetes.49.4.662

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

1.  Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.

Authors:  Sumon Roy; Dongjoon Kim; Cristina Hernández; Rafael Simó; Sayon Roy
Journal:  Exp Eye Res       Date:  2015-08-18       Impact factor: 3.467

Review 2.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

3.  Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors.

Authors:  Aisha I Kelly-Cobbs; Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Vera Portik-Dobos; Maribeth Johnson; Adviye Ergul
Journal:  J Pharmacol Exp Ther       Date:  2010-12-23       Impact factor: 4.030

4.  Endothelin-1 receptor blockade prevented the electrophysiological dysfunction in cardiac myocytes of streptozotocin-induced diabetic rats.

Authors:  Yanfeng Ding; Ruijiao Zou; Robert L Judd; Juming Zhong
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

5.  Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.

Authors:  Kyle Trudeau; Sumon Roy; Wen Guo; Cristina Hernández; Marta Villarroel; Rafael Simó; Sayon Roy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-11       Impact factor: 4.799

6.  Glucose-induced Akt1 activation mediates fibronectin synthesis in endothelial cells.

Authors:  X Xin; Z A Khan; S Chen; S Chakrabarti
Journal:  Diabetologia       Date:  2005-09-29       Impact factor: 10.122

Review 7.  Endothelin, astrocytes and glaucoma.

Authors:  Ganesh Prasanna; Raghu Krishnamoorthy; Thomas Yorio
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

8.  Effect of chronic endothelin blockade on PKC isoform distribution in mesenteric arteries from diabetic rats.

Authors:  Jihong Jiang; Lili Zhang; Kathleen M Macleod; John H McNeill
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

9.  Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway.

Authors:  Bin Zhang; Kevin K Zhou; Jian-xing Ma
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

10.  Endothelin-1 traps potently reduce pathologic markers back to basal levels in an in vitro model of diabetes.

Authors:  Arjun Jain; Shali Chen; Hannah Yong; Subrata Chakrabarti
Journal:  J Diabetes Metab Disord       Date:  2018-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.